Stock AORT ARTIVION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Artivion, Inc.

Equities

AORT

US2289031005

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
23.6 USD -1.05% Intraday chart for Artivion, Inc. -0.76% +31.99%
May. 07 Stifel Adjusts Price Target on Artivion to $25 From $22, Maintains Buy Rating MT
May. 07 Needham Adjusts Price Target on Artivion to $30 From $25, Maintains Buy Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,016 917.4 800.4 488.8 733.9 984.9 - -
Enterprise Value (EV) 1 1,016 917.4 1,058 761.4 733.9 984.9 984.9 984.9
P/E ratio 542 x -53.7 x -53.6 x -25.3 x -23.8 x 3,933 x 472 x 1,180 x
Yield - - - - - - - -
Capitalization / Revenue 3.68 x 3.62 x 2.68 x 1.56 x 2.07 x 2.52 x 2.29 x 2.08 x
EV / Revenue 3.68 x 3.62 x 2.68 x 1.56 x 2.07 x 2.52 x 2.29 x 2.08 x
EV / EBITDA 21.5 x 24.3 x 18.1 x 11.8 x 13.6 x 14.1 x 11.7 x 10.1 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - - 2.7 x 1.72 x - - - -
Nbr of stocks (in thousands) 37,504 38,857 39,330 40,329 41,049 41,734 - -
Reference price 2 27.09 23.61 20.35 12.12 17.88 23.60 23.60 23.60
Announcement Date 2/13/20 2/11/21 2/17/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 276.2 253.2 298.8 313.8 354 391.3 429.5 473.9
EBITDA 1 47.23 37.76 44.28 41.56 53.82 70.1 84.25 97.85
EBIT 1 17.04 2.441 8.117 6.201 5.742 49.39 43.22 49.8
Operating Margin 6.17% 0.96% 2.72% 1.98% 1.62% 12.62% 10.07% 10.51%
Earnings before Tax (EBT) 1 1.644 -17.17 -14.83 -14.98 -21.59 15.31 13.77 27.3
Net income 1 1.72 -16.68 -14.83 -19.19 -30.69 7.348 11.48 20.5
Net margin 0.62% -6.59% -4.96% -6.12% -8.67% 1.88% 2.67% 4.33%
EPS 2 0.0500 -0.4400 -0.3800 -0.4800 -0.7500 0.006000 0.0500 0.0200
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 2/13/20 2/11/21 2/17/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 79.39 77.21 80.34 76.84 79.4 83.23 89.25 87.85 93.67 97.43 97.6 94.65 101.6 105.6 108.7
EBITDA 1 10.77 9.987 10.26 10.36 10.96 10.8 13.82 13.86 15.33 17.31 16.25 16.63 19.92 20.46 21.11
EBIT 1 -9.339 1.636 4.541 -4.106 4.13 -3.861 7.675 -1.244 3.172 25.31 6.208 7.832 10.02 10.18 12
Operating Margin -11.76% 2.12% 5.65% -5.34% 5.2% -4.64% 8.6% -1.42% 3.39% 25.98% 6.36% 8.28% 9.86% 9.64% 11.04%
Earnings before Tax (EBT) 1 -16.09 -2.429 -3.3 -12.53 3.277 -8.919 -2.657 -9.419 -0.591 12.78 -1.345 0.2925 2.32 2.5 4.31
Net income 1 -20.1 -3.389 -4.259 -13.71 2.169 -13.53 -3.382 -9.801 -3.975 7.533 -1.85 -0.145 1.808 1.785 3.535
Net margin -25.32% -4.39% -5.3% -17.85% 2.73% -16.26% -3.79% -11.16% -4.24% 7.73% -1.9% -0.15% 1.78% 1.69% 3.25%
EPS 2 -0.5100 -0.0800 -0.1100 -0.3400 0.0500 -0.3300 -0.0800 -0.2400 -0.1000 0.1800 -0.0900 -0.0620 -0.0160 0.0350 0.0700
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/17/22 5/5/22 8/4/22 11/3/22 2/16/23 5/4/23 8/3/23 11/2/23 2/15/24 5/6/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - 258 273 - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - 5.822 x 6.558 x - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 0.61% - 1.56% 0.71% - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - 7.540 7.050 - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - - - 9.02 7.43 7 - -
Capex / Sales - - - 2.87% 2.1% 1.79% - -
Announcement Date 2/13/20 2/11/21 2/17/22 2/16/23 2/15/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Artivion, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
23.6 USD
Average target price
26.75 USD
Spread / Average Target
+13.35%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ARTIVION, INC. Stock Artivion, Inc.
+31.99% 985M
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.16% 178B
MEDTRONIC PLC Stock Medtronic plc
-1.23% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.86% 67.04B
DEXCOM, INC. Stock DexCom, Inc.
-4.28% 47.23B
CENCORA, INC. Stock Cencora, Inc.
+10.32% 44.62B
HOYA CORPORATION Stock Hoya Corporation
+8.14% 42.5B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.76% 29.99B
TERUMO CORPORATION Stock Terumo Corporation
+15.53% 25.22B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.88% 24.14B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. AORT Stock
  4. Financials Artivion, Inc.